J&J proposes vaccine ‘booster’ trial In South Africa
Johnson & Johnson may host a COVID-19 booster shot trial in South Africa.
Johnson & Johnson may host a COVID-19 booster shot trial in South Africa.
Johnson & Johnson delivered 40 000 doses on Saturday. Three more batches are expected this week.
According to the FDA, the Johnson & Johnson vaccine can reduce asymptomatic transmission by 74%.
The nationwide vaccine drive will kickstart as early as Wednesday in some areas.